Linetsky David, an officer at Phreesia, Inc., has reported two recent transactions involving the company’s common stock. This activity, filed on October 26, 2026, is significant as it demonstrates the ongoing investment actions of executives within the company.
Phreesia, Inc. operates in the business services sector and is known for providing healthcare solutions. The company is listed under the Central Index Key 0001412408 and is incorporated in Delaware. It has been active in filing various forms with the SEC, including multiple Form 4 submissions in recent months.
According to the filing, Linetsky David executed two transactions on October 22, 2026. In the first transaction, he acquired 35 shares at a price of $9.15 per share. In the second transaction, he acquired another 35 shares at a price of $10.35 per share. Following these transactions, he now owns a total of 22,232 shares in Phreesia, Inc.
The filing also notes that these shares were acquired through a spouse, indicating a personal investment strategy rather than a direct transaction by Linetsky David himself. This type of transaction can often reflect confidence in the company’s future performance and may influence investor sentiment.
These transactions may affect various stakeholders, including other executives, investors, and analysts who monitor Phreesia’s market activities. The involvement of executives in stock transactions can be seen as a signal of their confidence in the company’s direction.
Details were not available in the SEC filing regarding any future plans or additional transactions. However, continued monitoring of executive stock transactions may provide insights into Phreesia’s performance and market positioning.